Stock search

Ticker or company name

TMO card

TMO price forecast

Thermo Fisher Scientific$691,33

P/E now is 36,5. Average over 5 years: 31,9 (range 29–35). The stock is 14% above its history.

Base · FY2030

$801,49+3,9% a year

The base case gives 3,9% a year, below your target of 10%.

Settings

%

No analyst consensus: assumptions come from the company's last 5 years. Change any in the table.

Assumptions by year

FY2026FY2027FY2028FY2029FY2030
Revenue growth, %
Net margin, %
Change in shares, %
Payout ratio, %
P/E low
P/E base
P/E high
Revenue$47,5 bn$50,7 bn$54,1 bn$57,8 bn$61,6 bn
Net income$6,94 bn$7,41 bn$7,90 bn$8,43 bn$9,00 bn
EPS$18,57$20,02$21,60$23,30$25,13

Changed values are highlighted. Bear and bull cases: growth ∓ 10,8%, margin ∓ 2 pp, low and high P/E.

Price at year end

  • Base
  • Bear – Bull
  • now $691,33

The dot is the base case, the line runs from bear to bull, the dashed line is today's price.

Result at the end of FY2030

Bear$369,03

Price change
−46,6%
A year
−13,8%
Fair value today
$252,81
Margin of safety
−63,4%

Base$801,49

Price change
+15,9%
A year
+3,9%
Fair value today
$547,27
Margin of safety
−20,8%

Bull$1 609,27

Price change
+132,8%
A year
+23,0%
Fair value today
$1 096,41
Margin of safety
+58,6%

What growth the price implies

For the stock to return 10% a year, revenue must grow 12,1% a year to FY2030 at a 14,6% margin and P/E 31,9.

Growth over 5 years
6,7%
Analyst consensus
no data
In your model
6,7%

Calculated from your assumptions. Not an investment recommendation.

Base · FY2030$801,49+3,9% a year